We used a two-color analysis system to assess the porphyrin uptake and
DNA content in four established cell lines of glioma employing flow c
ytometry (FCM). The FCM study revealed porphyrin uptake in all cells,
regardless of the phase of the cell cycle they were in. However, those
in the G0/G1 phase showed moderate uptake of porphyrin and those in t
he G2/M phase showed a higher uptake. These results indicated the adva
ntage of using porphyrin as the carrier of tumor targeting agents as a
therapeutic strategy for malignant tumors. (C) 1998 Elsevier Science
Ireland Ltd. All rights reserved.